Safety and feasibility of anlotinib in children with high risk, recurrent or refractory sarcomas: an open-label, single-centre, single-arm, phase Ia/Ib trial
安罗替尼治疗高危、复发或难治性肉瘤患儿的安全性和可行性：一项开放标签、单中心、单臂 Ia/Ib 期试验
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2025.103258
Lu, Suying; Que, Yi; Liu, Dongyang; Sun, Feifei; Yao, Xueting; Deng, Liting; Zhan, Jing; Huang, Junting; Cai, Ruiqing; Wang, Xin; Zhu, Shixing; Zhen, Zijun; Zhu, Jia; Wang, Juan; Zhang, Yizhuo
